Filtering by:
Breast CancerFDA Approves First PI3K Inhibitor for Breast Cancer
The US Food and Drug Administration (FDA) has approved the first treatment of its kind for a certain type of breast cancer caused by an inherited genetic mutation. Piqray (alpelisib) is a targeted therapy called a PI3K inhibitor.
Breast Cancer Patients Make Recommendations to Address High Health Care Costs
Breast cancer patients, especially if they have lymphedema, face an especially high cost of health care according to authors of a paper published March 6, 2019 in Cancer, a peer-reviewed medical journal of the American Cancer Society.
FDA Approves Immunotherapy for Breast Cancer
The US Food and Drug Administration today approved the first immunotherapy treatment for breast cancer. It approved a combination of Tecentriq (atezolizumab) and Abraxane (nab-paclitaxel) for people with advanced triple negative breast cancer.
Facts & Figures 2019: US Cancer Death Rate has Dropped 27% in 25 Years
The death rate from cancer in the US has declined steadily over the past 25 years, according to annual statistics reporting from the American Cancer Society.
New Drug Reduces Recurrence Risk for Some Women With Early-Stage Breast Cancer
Research presented at the San Antonio Breast Cancer Symposium may result in a new standard of care for some people with HER2 positive, early stage breast cancer.